Skip to main content
ADALTA LIMITED logo

ADALTA LIMITED — Investor Relations & Filings

Ticker · 1AD ISIN · AU0000001AD2 LEI · 254900XT3BQIT6GR6M94 ASX Professional, scientific and technical activities
Open in API
Filings indexed 726 across all filing types
Latest filing 2023-10-19 AGM Information
Country AU Australia
Listing ASX 1AD

About ADALTA LIMITED

https://adalta.com.au/

AdAlta Limited is a clinical-stage biotechnology company focused on the discovery and development of a new class of protein therapeutics called i-bodies. The company utilizes its proprietary i-body platform to engineer highly stable, small-format proteins that mimic the binding characteristics of shark antibodies. These i-bodies are designed to target complex disease-related proteins that are often inaccessible to traditional monoclonal antibodies. AdAlta's lead therapeutic candidate, AD-214, is being developed for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic conditions. The platform's versatility allows for the creation of diverse therapeutic leads across multiple disease areas, including inflammation and oncology, by leveraging the unique structural properties of the human protein scaffold-based i-body library.

Recent filings

Filing Released Lang Actions
Letter to Shareholders, Notice of AGM & Proxy Form 36 pages 1.5MB
AGM Information Classification · 100% confidence The document is a detailed notice and explanatory memorandum for the 2023 Annual General Meeting (AGM) of AdAlta Limited. It includes the date, time, location (hybrid meeting), instructions for shareholders to vote, proxy form details, and the agenda for the meeting. The agenda includes tabling the Annual Report for the year ended 30 June 2023, adoption of the Remuneration Report, re-election of a director, and ratification of prior share issues. The document is clearly a notice and proxy solicitation for the AGM, not the actual Annual Report or financial statements themselves. It is a formal communication to shareholders to inform them about the AGM and solicit their votes on various resolutions. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document is lengthy (15,000 characters) and contains detailed meeting and voting information, consistent with an AGM notice and explanatory memorandum rather than a simple announcement or proxy statement alone. Therefore, the correct classification is AGM Information (AGM-R).
2023-10-19 English
AD-214 oral presentation at MPGPCR23 2 pages 379.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 October 2023 from AdAlta Limited. It announces that the company has been selected for an extended oral presentation at a pharmacology conference (MPGPCR 2023). The content focuses on the presentation details, the company's technology platform, and upcoming clinical studies. There are no financial statements, earnings data, or regulatory filings such as annual or interim reports. The document is a corporate announcement about a scientific conference presentation and company updates, not a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. Therefore, the document fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-10-18 English
R&D tax refund received & R&D Loan repayment terms extended 2 pages 222.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 October 2023 from AdAlta Limited regarding the receipt of its FY2023 Research and Development Tax Incentive refund and the extension of loan repayment terms. It discusses financing and loan facility amendments but does not contain financial statements or detailed financial results. It is a corporate update on capital/financing matters rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 5266 characters, sufficient for a substantive announcement but not a full report.
2023-10-17 English
Investor roadshow with IPF survivor Bill van Nierop 3 pages 390.0KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement dated 13 October 2023 from AdAlta Limited inviting shareholders and potential investors to a series of upcoming investor information sessions and presentations. It includes details about the events, registration information, and background on the company and its clinical programs. There are no financial statements, earnings data, or detailed management analysis. The document is primarily an announcement of investor presentations and updates rather than the presentations themselves or a formal report. It does not contain any voting results, board changes, or regulatory certifications. The content fits best as an Investor Presentation announcement or invitation rather than the presentation itself. Given the nature of the document as an announcement of upcoming investor sessions and updates, the most appropriate classification is Investor Presentation (IP). The document length (7771 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2023-10-12 English
Notification of cessation of securities - 1AD 4 pages 23.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for ADALTA LIMITED. It provides specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement about changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement related to capital changes. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 3637 characters, which is consistent with an announcement rather than a full report.
2023-10-11 English
Notification regarding unquoted securities - 1AD 6 pages 28.0KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by AdAlta Limited. It details the number and type of securities issued, issue dates, and compliance with ASX listing rules. The content is focused on the announcement of new securities issuance rather than a financial report or detailed analysis. It matches the description of a Share Issue/Capital Change announcement, which covers new share issues or capital changes. The document is about notifying the market of these changes, consistent with the SHA category.
2023-10-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.